Sophia Genetics Expands Precision Oncology Research with Cambridge Lab Integration
I'm PortAI, I can summarize articles.
Sophia Genetics SA is expanding its precision oncology research by integrating the East Genomics laboratory in Cambridge into its network. The lab will use the SOPHiA DDM™ Platform for cancer profiling, focusing on solid tumour samples. This move aims to enhance the understanding of complex cancers for patients in the East of England.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments